With interest in VR/AR ramping up in anticipation of Apple’s new iPhone release later this year that will include several apps for virtual and augmented reality, we are updating the buy limits on two of our “Three Hot Stocks for the $150 Billion Virtual Reality Revolution”, as follows:

Himax Technologies (HIMX) buy limit raised from $7.50 to $9;

Microvision (MVIS) buy limit raised from $2 to $3.

In addition, we are closing out our position in Synergy Pharmaceuticals (SGYP) given continuing uncertainty over passage of a replacement for Obamacare. We still like the company from a long-term perspective, but we feel more confident in the near-term prospects for other sectors such as AR/VR, so we are concentrating on those. The call option on Synergy that expires tomorrow currently has no intrinsic value so there is nothing you need to do with it.